Tuesday, 17 Sep 2019

You are here

The RheumNow Week in Review - 19 January 2018

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report covers the rising cost of adalimumab, infections in myositis, phyisician burnout, biologics in Still's disease and weight loss benefits in RA. 

  1. Checkpoint inhibitor use in autoimmune and inflammatory disease (AID) pts is associated with higher rates of immune-related AE 44.4%) with half these being a flare of underlying AID. https://t.co/aNHIE86B8r
  2. NY Times article reports 2015 price of 2 syringes of Humira is $2669 in USA; $1362 in UK; $1253 in Spain; $822 in Switzerland and $552 in South Africa. https://t.co/ulZFTxsRBU 
  3. RT @kdao2011 Let your patients know the benefits of the occasional swear word: Cursing can help us withstand pain and more. https://t.co/x3NVNiT5Ir … via @WSJ !#*/@!^$!
  4. Cohort study of 204 myositis pts shows 6.4% develop opportunistic infx (OI) - 55% occuring in 1st yr, strongly assoc w/ high dose Steroids, biologics use, fever @onset, 4+ immunosuppressive use https://t.co/jeE2si2av6
  5. Taiwan claims study of 18267 RA patients (vs 73k non-RA) - RA pts have 2 fold increase in Hearing loss; moreso in men, elderly; worse w/ HTN and CV comrobidities. Lower rates seen w/ all RA therapy, NSAIDs, Pred, DMARDs, TNFi https://t.co/TZSFKpXGmX
  6. Rheumatology Physician Burnout and Depression
  7. IL-1 and IL-6 Inhibition Preferred in Systemic JIA  
  8. Weight Loss Linked to RA Improvement.  https://t.co/1E3xSvFj35
  9. Laparoscopic Gastric Sleeve Compared to Bypass Bariatric Surgery  

 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast – The End of Arthritis (9.13.19)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

RheumNow Podcast – Do’s and Don’ts in Spondylitis (9.5.19)

Dr. Jack Cush reviews the news and important research published in the last two weeks on RheumNow.com.

Influenza Vaccination Update

FDA's Vaccines and Related Biological Products Advisory Committee met in Silver Spring, Maryland, on March 6 and 22, 2019, to select the influenza viruses for the composition of the influenza vaccine for the 2019-2020 U.S. influenza season.

RheumNow Podcast - I Wanna New Drug (8-30-19)

Dr. Jack Cush vents on choosing new therapies in rheumatoid arthritis.

RheumNow Podcast – Upadacitinib FDA Approved for RA (8.23.19)

Dr. Jack Cush reports on the news and journal reports from the past week on RheumNow.com, including: how your genetics may shape your microbiome; GERD as a risk factor for TMJ?; how can MDA-5+ dermatomyositis be any worse; new drug happenings; StillsNow.com; and more.